We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ALIM market cap is 174.86M. The company's latest EPS is USD -0.4086 and P/E is -8.47.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.6M | 14.03M | 13.55M | 17.54M | 23.36M |
| Operating Income | -3.41M | -2.11M | -3.3M | -1.21M | 1.85M |
| Net Income | -5.26M | -3.78M | -4.98M | -10.7M | -1.77M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 53.94M | 50.82M | 59.03M | 54.13M | 80.75M |
| Operating Income | -5.27M | -501k | -201k | -11.64M | -1.93M |
| Net Income | -10.44M | -5.34M | -4.37M | -18.11M | -21.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.43M | 42.6M | 48.24M | 154.92M | 154.19M |
| Total Liabilities | 61.51M | 63.41M | 67.16M | 108.69M | 105.35M |
| Total Equity | -18.08M | -20.81M | -18.92M | 46.23M | 48.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 50.31M | 50.86M | 58.52M | 42.6M | 153.52M |
| Total Liabilities | 54.75M | 58.83M | 61.13M | 63.41M | 107.35M |
| Total Equity | -4.45M | -7.98M | -2.61M | -20.81M | 46.17M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.72M | -9.98M | -2.21M | -8.21M | -18.03M |
| Investing | -171k | -255k | -9k | -75.44M | -75.45M |
| Financing | -109k | -302k | 10M | 97.12M | 96.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.15M | -2.19M | -3.22M | -9.98M | -14.26M |
| Investing | -174k | -620k | -621k | -255k | -75.53M |
| Financing | 869k | 3.88M | 9.82M | -302k | 96.5M |
| Market Cap | 174.86M |
| Price to Earnings Ratio | -8.47 |
| Price to Sales Ratio | 2.24 |
| Price to Cash Ratio | 15.02 |
| Price to Book Ratio | 3.92 |
| Dividend Yield | - |
| Shares Outstanding | 52.35M |
| Average Volume (1 week) | 40.6k |
| Average Volume (1 Month) | 70.49k |
| 52 Week Change | 67.00% |
| 52 Week High | 4.40 |
| 52 Week Low | 1.57 |
| Spread (Intraday) | 0.99 (25.06%) |
| Company Name | Alimera Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.alimerasciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
